← back to database
OMX Ventures backs early-stage biotech and computational biology startups. They invest at the intersection of biology, big data, and AI, targeting therapeutics, bio tools, diagnostics, and synthetic biology platforms. They operate as a venture capital firm that provides funding and helps founders build teams and overcome early technical challenges. The focus spans industrial biology and life sciences tools, aiming to scale innovations where biology meets computing.
Primary stage
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Dan FeroManaging Director
- Craig AsherManaging Director
- Nick HaftManaging Director
- Tim RichardsonVenture Partner
- Paul ConleyVenture Partner
- Fred SweeneyVenture Partner
- Swetha MuraliVice President
How to reach them
Notable investments
10x Genomics, Ginkgo Bioworks, Twist Bioscience, Compass Pathways, Inscripta, Tasso